title: Has publication of the results of the ORACLE Children Study changed practice in the UK?
abstract: OBJECTIVE
  To investigate whether publication of the results of the ORACLE Children's Study, a 7-year follow-up of the ORACLE trial, changed practice with regard to the routine prescription of antibiotics to women with preterm rupture of membranes or spontaneous preterm labour (intact membranes).
  
  
  METHODS
  A comparative questionnaire survey of clinical practice in November 2007 (before publication) and March 2009 (after publication).
  
  
  METHODS
  Lead obstetricians for labour wards of all maternity units in the UK.
  
  
  METHODS
  Self-administered questionnaires requested information about the routine prescription of antibiotics to women with either preterm rupture of membranes or spontaneous preterm labour (intact membranes).
  
  
  METHODS
  Change in practice for prescription of antibiotics.
  
  
  RESULTS
  The response rate was 166/214 (78%) in 2007 and 158/209 (76%) in 2009. In total, 120 maternity units responded on both occasions. For women with preterm rupture of membranes, 162/214 (98%) in 2007 and 151/158 (96%) in 2009 maternity units reported that they prescribed antibiotics, with the majority using erythromycin (98%). For women with spontaneous preterm labour (intact membranes), 35/166 (21%) in 2007 and 25/158 (16%) in 2009 maternity units reported that they routinely prescribed antibiotics. The findings from units who responded on both occasions are similar.
  
  
  CONCLUSIONS
  There has been little change in the reported prescription of antibiotics to women with either preterm rupture of membranes or spontaneous preterm labour following publication of the ORACLE Children's Study. This suggests that current practice may require updated guidance.
authors.affiliation: School of Health and Population Sciences, University of Birmingham, Edgbaston, UK. s.kenyon@bham.ac.uk
authors.forename: S
authors.initials: S
authors.lastname: Kenyon
authors.forename: K
authors.initials: K
authors.lastname: Pike
authors.forename: D
authors.initials: D
authors.lastname: Jones
authors.forename: P
authors.initials: P
authors.lastname: Brocklehurst
authors.forename: N
authors.initials: N
authors.lastname: Marlow
authors.forename: A
authors.initials: A
authors.lastname: Salt
authors.forename: D
authors.initials: D
authors.lastname: Taylor
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy*; D005500:Follow-Up Studies; D006771:Hospitals, Maternity; D006801:Humans; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D009774:Obstetrics / Q000592:standards*; D011247:Pregnancy; D011364:Professional Practice; D016032:Randomized Controlled Trials as Topic; D011795:Surveys and Questionnaires; D006113:United Kingdom
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin